Aperio Group’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $16.4M | Sell |
109,560
-2,407
| -2% | -$340K | 0.05% | 375 |
|
|
2020
Q3 | $14.8M | Buy |
111,967
+6,737
| +6% | +$880K | 0.05% | 351 |
|
|
2020
Q2 | $12.2M | Buy |
105,230
+2,910
| +3% | +$335K | 0.05% | 399 |
|
|
2020
Q1 | $10M | Buy |
102,320
+2,694
| +3% | +$353K | 0.04% | 408 |
|
|
2019
Q4 | $14.5M | Buy |
99,626
+2,516
| +3% | +$347K | 0.05% | 394 |
|
|
2019
Q3 | $12.9M | Buy |
97,110
+3,916
| +4% | +$506K | 0.05% | 403 |
|
|
2019
Q2 | $10.7M | Sell |
93,194
-7,505
| -7% | -$879K | 0.04% | 455 |
|
|
2019
Q1 | $12.5M | Buy |
100,699
+3,042
| +3% | +$346K | 0.05% | 380 |
|
|
2018
Q4 | $9.83M | Sell |
97,657
-17,220
| -15% | -$1.94M | 0.05% | 414 |
|
|
2018
Q3 | $14.7M | Buy |
114,877
+553
| +0.5% | +$65.8K | 0.06% | 331 |
|
|
2018
Q2 | $12.4M | Sell |
114,324
-22,850
| -17% | -$2.49M | 0.06% | 367 |
|
|
2018
Q1 | $14.5M | Buy |
137,174
+8,585
| +7% | +$997K | 0.07% | 314 |
|
|
2017
Q4 | $15.1M | Buy |
128,589
+6,387
| +5% | +$722K | 0.08% | 302 |
|
|
2017
Q3 | $13.9M | Buy |
122,202
+1,516
| +1% | +$175K | 0.08% | 305 |
|
|
2017
Q2 | $15M | Buy |
120,686
+6,127
| +5% | +$726K | 0.09% | 260 |
|
|
2017
Q1 | $13.6M | Buy |
114,559
+10,559
| +10% | +$1.2M | 0.09% | 256 |
|
|
2016
Q4 | $10.4M | Sell |
104,000
-64,376
| -38% | -$6.9M | 0.08% | 289 |
|
|
2016
Q3 | $21.3M | Buy |
168,376
+705
| +0.4% | +$87.1K | 0.15% | 150 |
|
|
2016
Q2 | $19.6M | Sell |
167,671
-56,850
| -25% | -$6.43M | 0.15% | 154 |
|
|
2016
Q1 | $23.2M | Buy |
224,521
+45,329
| +25% | +$4.38M | 0.2% | 121 |
|
|
2015
Q4 | $17.8M | Buy |
179,192
+90,485
| +102% | +$8.85M | 0.16% | 153 |
|
|
2015
Q3 | $8.09M | Buy |
88,707
+15,690
| +21% | +$1.57M | 0.08% | 294 |
|
|
2015
Q2 | $7.74M | Buy |
73,017
+3,003
| +4% | +$332K | 0.08% | 301 |
|
|
2015
Q1 | $7.99M | Buy |
70,014
+1,249
| +2% | +$143K | 0.09% | 278 |
|
|
2014
Q4 | $7.57M | Buy |
68,765
+5,016
| +8% | +$529K | 0.09% | 265 |
|
|
2014
Q3 | $6.22M | Buy |
63,749
+1,123
| +2% | +$110K | 0.08% | 298 |
|
|
2014
Q2 | $6.32M | Buy |
62,626
+3,401
| +6% | +$332K | 0.09% | 275 |
|
|
2014
Q1 | $5.44M | Buy |
+59,225
| New | +$5.46M | 0.08% | 330 |
|
|
2013
Q4 | – | Sell |
-48,872
| Closed | -$4.23M | – | 316 |
|
|
2013
Q3 | $3.9M | Buy |
48,872
+4,896
| +11% | +$385K | 0.08% | 341 |
|
|
2013
Q2 | $3.2M | Buy |
+43,976
| New | +$3.29M | 0.08% | 332 |
|
Other funds holding ZBH
N
Aperio Group's ZBH Position: Q4 2020 in Review
Aperio Group reduced its Zimmer Biomet (ZBH) stake by 2.1% in Q4 2020, selling an estimated $340K and leaving 109,560 shares worth $16.4M. The position accounts for 0.05% of the portfolio, ranked #375.
Aperio Group first reported a position in ZBH in Q2 2013 and has held it in 30 quarters since. The position peaked at $23.2M in Q1 2016. 1,012 funds tracked by Wall St. Rank hold ZBH as of Q4 2020.
- Aperio Group held 109,560 shares of Zimmer Biomet worth $16.4M as of Q4 2020.
- Aperio Group sold 2,407 Zimmer Biomet shares in Q4 2020, an estimated $340K.
- Zimmer Biomet made up 0.05% of Aperio Group's portfolio in Q4 2020, its #375 holding.
- Aperio Group first reported a position in Zimmer Biomet in Q2 2013 and has held it in 30 quarters since.
- Aperio Group's Zimmer Biomet position peaked at $23.2M in Q1 2016.
- 1,012 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2020.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.